These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15119501)

  • 21. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
    Hoye A; Iakovou I; Ge L; van Mieghem CA; Ong AT; Cosgrave J; Sangiorgi GM; Airoldi F; Montorfano M; Michev I; Chieffo A; Carlino M; Corvaja N; Aoki J; Rodriguez Granillo GA; Valgimigli M; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW; Colombo A
    J Am Coll Cardiol; 2006 May; 47(10):1949-58. PubMed ID: 16697310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
    Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
    Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
    Shammas NW; Shammas G; Bryan D; Rauba J; Dippel E; Jerin M
    J Invasive Cardiol; 2009 Jun; 21(6):266-9. PubMed ID: 19494402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial.
    Goy JJ; Kaufmann U; Hurni M; Cook S; Versaci F; Ruchat P; Bertel O; Pieper M; Meier B; Chiarello L; Eeckhout E;
    J Am Coll Cardiol; 2008 Sep; 52(10):815-7. PubMed ID: 18755343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent.
    Ge L; Tsagalou E; Iakovou I; Sangiorgi GM; Corvaja N; Airoldi F; Chieffo A; Montorfano M; Michev I; Colombo A
    Am J Cardiol; 2005 Mar; 95(6):757-60. PubMed ID: 15757605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
    Buszman PE; Kiesz SR; Bochenek A; Peszek-Przybyla E; Szkrobka I; Debinski M; Bialkowska B; Dudek D; Gruszka A; Zurakowski A; Milewski K; Wilczynski M; Rzeszutko L; Buszman P; Szymszal J; Martin JL; Tendera M
    J Am Coll Cardiol; 2008 Feb; 51(5):538-45. PubMed ID: 18237682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival for stenting vs. balloon angioplasty for the treatment of coronary artery disease in patients with ischemic left ventricular dysfunction.
    Lipinski MJ; Martin RE; Cowley MJ; Goudreau E; Malloy WN; Vetrovec GW
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):547-53. PubMed ID: 16216018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
    Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting.
    Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2011 Oct; 124(19):3022-9. PubMed ID: 22040548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome.
    Marzocchi A; Ortolani P; Piovaccari G; Marrozzini C; Nobile G; Palmerini T; Marinucci L; Saia F; Bacchi Reggiani ML; Branzi A; Magnani B
    Coron Artery Dis; 1999; 10(2):81-8. PubMed ID: 10219513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Nygård O; Nordrehaug JE; Refsum H; Ueland PM; Farstad M; Vollset SE
    N Engl J Med; 1997 Jul; 337(4):230-6. PubMed ID: 9227928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial and follow-up results of the European Seaquence coronary stent registry.
    Hamon M; Petrescu V; Rossi P; Commeau P; Wittenberg O; Jouve B; Brunel P; Gommeau A; Macaya C; Betriu A; Serra A; Viecca M; Bortone A; Marzocchi A; Bush U; Grube E; Blanke H; Fleck E; Grollier G
    J Interv Cardiol; 2004 Feb; 17(1):9-15. PubMed ID: 15009764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting.
    Yeh JK; Chen CC; Hsieh MJ; Tsai ML; Yang CH; Chen DY; Chang SH; Wang CY; Lee CH; Hsieh IC
    J Atheroscler Thromb; 2017 Jul; 24(7):696-705. PubMed ID: 27803490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.